2-(1-hydroxy-2-phenylethylidene)-5,5-dimethyl-3-(2-phenylethylimino)cyclohexan-1-one
C24H27NO2 — CID 135416798
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(1-hydroxy-2-phenylethylidene)-5,5-dimethyl-3-(2-phenylethylimino)cyclohexan-1-one
2-(1-hydroxy-2-phenylethylidene)-5,5-dimethyl-3-(2-phenylethylimino)cyclohexan-1-one (PubChem CID 135416798) has the molecular formula C24H27NO2 and a molecular weight of 361.48 g/mol. Its IUPAC name is 2-(1-hydroxy-2-phenylethylidene)-5,5-dimethyl-3-(2-phenylethylimino)cyclohexan-1-one.
Molecular Properties
| Compound Name | 2-(1-hydroxy-2-phenylethylidene)-5,5-dimethyl-3-(2-phenylethylimino)cyclohexan-1-one |
|---|---|
| PubChem CID | 135416798 |
| Molecular Formula | C24H27NO2 |
| Molecular Weight | 361.48 g/mol |
| Exact Mass | 361.20 |
| IUPAC Name | 2-(1-hydroxy-2-phenylethylidene)-5,5-dimethyl-3-(2-phenylethylimino)cyclohexan-1-one |
| SMILES | CC1(C)CC(=O)C(=C(O)Cc2ccccc2)/C(=N/CCc2ccccc2)C1 |
| InChI | InChI=1S/C24H27NO2/c1-24(2)16-20(25-14-13-18-9-5-3-6-10-18)23(22(27)17-24)21(26)15-19-11-7-4-8-12-19/h3-12,26H,13-17H2,1-2H3/b23-21?,25-20+ |
| InChIKey | UPSMDXTWPWIEGZ-QGOCBHNSSA-N |
| XLogP | 5.11 |
| TPSA | 49.66 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 361.48 |
| LogP ≤ 5 | 5.11 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135416798 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.